These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38536229)

  • 1. Combinatorial Approach with Mass Spectrometry and Lectin Microarray Dissected Site-Specific Glycostem and Glycoleaf Features of the Virion-Derived Spike Protein of Ancestral and γ Variant SARS-CoV-2 Strains.
    Hiono T; Sakaue H; Tomioka A; Kaji H; Sasaki M; Orba Y; Sawa H; Kuno A
    J Proteome Res; 2024 Apr; 23(4):1408-1419. PubMed ID: 38536229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the N-glycosylation profiles of the spike proteins from the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2.
    Wang D; Baudys J; Osman SH; Barr JR
    Anal Bioanal Chem; 2023 Aug; 415(19):4779-4793. PubMed ID: 37354227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of N-glycosylation in spike antigenicity for the SARS-CoV-2 gamma variant.
    Pegg CL; Modhiran N; Parry RH; Liang B; Amarilla AA; Khromykh AA; Burr L; Young PR; Chappell K; Schulz BL; Watterson D
    Glycobiology; 2024 Mar; 34(2):. PubMed ID: 38048640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific glycan analysis of the SARS-CoV-2 spike.
    Watanabe Y; Allen JD; Wrapp D; McLellan JS; Crispin M
    Science; 2020 Jul; 369(6501):330-333. PubMed ID: 32366695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific glycosylation of SARS-CoV-2: Big challenges in mass spectrometry analysis.
    Campos D; Girgis M; Sanda M
    Proteomics; 2022 Aug; 22(15-16):e2100322. PubMed ID: 35700310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
    Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
    Elife; 2020 Oct; 9():. PubMed ID: 33103998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-glycosylation profiles of the SARS-CoV-2 spike D614G mutant and its ancestral protein characterized by advanced mass spectrometry.
    Wang D; Zhou B; Keppel TR; Solano M; Baudys J; Goldstein J; Finn MG; Fan X; Chapman AP; Bundy JL; Woolfitt AR; Osman SH; Pirkle JL; Wentworth DE; Barr JR
    Sci Rep; 2021 Dec; 11(1):23561. PubMed ID: 34876606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Select SARS-CoV-2 N-Linked Glycan and Variant of Concern Spike Protein Mutations on C-Type Lectin-Receptor-Mediated Infection.
    Bains A; Guan W; LiWang PJ
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct shifts in site-specific glycosylation pattern of SARS-CoV-2 spike proteins associated with arising mutations in the D614G and Alpha variants.
    Kuo CW; Yang TJ; Chien YC; Yu PY; Hsu SD; Khoo KH
    Glycobiology; 2022 Feb; 32(1):60-72. PubMed ID: 34735575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of the Glycan Complement of SARS-CoV-2 Spike Proteins Using Signature Ions-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation (EThcD) Mass Spectrometry.
    Wang D; Baudys J; Bundy JL; Solano M; Keppel T; Barr JR
    Anal Chem; 2020 Nov; 92(21):14730-14739. PubMed ID: 33064451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-depth characterization of protein N-glycosylation for a COVID-19 variant-design vaccine spike protein.
    Huang J; Hou S; An J; Zhou C
    Anal Bioanal Chem; 2023 Mar; 415(8):1455-1464. PubMed ID: 36698045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data-independent acquisition mass spectrometry for site-specific glycoproteomics characterization of SARS-CoV-2 spike protein.
    Chang D; Klein JA; Nalehua MR; Hackett WE; Zaia J
    Anal Bioanal Chem; 2021 Dec; 413(29):7305-7318. PubMed ID: 34635934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein.
    Zhang S; Go EP; Ding H; Anang S; Kappes JC; Desaire H; Sodroski JG
    J Virol; 2022 Feb; 96(3):e0162621. PubMed ID: 34817202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific characterization of SARS-CoV-2 spike glycoprotein receptor-binding domain.
    Antonopoulos A; Broome S; Sharov V; Ziegenfuss C; Easton RL; Panico M; Dell A; Morris HR; Haslam SM
    Glycobiology; 2021 Apr; 31(3):181-187. PubMed ID: 32886791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives.
    Barre A; Van Damme EJM; Simplicien M; Le Poder S; Klonjkowski B; Benoist H; Peyrade D; Rougé P
    Cells; 2021 Jun; 10(7):. PubMed ID: 34203435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2.
    Shajahan A; Supekar NT; Gleinich AS; Azadi P
    Glycobiology; 2020 Dec; 30(12):981-988. PubMed ID: 32363391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural O-Glycoform Heterogeneity of the SARS-CoV-2 Spike Protein Receptor-Binding Domain Revealed by Top-Down Mass Spectrometry.
    Roberts DS; Mann M; Melby JA; Larson EJ; Zhu Y; Brasier AR; Jin S; Ge Y
    J Am Chem Soc; 2021 Aug; 143(31):12014-12024. PubMed ID: 34328324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity.
    Zhang F; Schmidt F; Muecksch F; Wang Z; Gazumyan A; Nussenzweig MC; Gaebler C; Caskey M; Hatziioannou T; Bieniasz PD
    mBio; 2024 Feb; 15(2):e0167223. PubMed ID: 38193662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plant lectins as versatile tools to fight coronavirus outbreaks.
    Simplicien M; Pério P; Sudor J; Barre A; Benoist H; Van Damme EJM; Rougé P
    Glycoconj J; 2023 Feb; 40(1):109-118. PubMed ID: 36418811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells.
    Bagdonaite I; Thompson AJ; Wang X; Søgaard M; Fougeroux C; Frank M; Diedrich JK; Yates JR; Salanti A; Vakhrushev SY; Paulson JC; Wandall HH
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33806155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.